GL
UTHR icon

GLG LLC’s United Therapeutics UTHR Stock Holding History

GLG LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100,000
Closed -$12.9M – 643
2014
Q3 		$12.9M Buy
+100,000
New +$10.3M 0.34% 87

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GLG LLC's UTHR Position: Q4 2017 in Review

GLG LLC held its United Therapeutics (UTHR) position steady in Q4 2017 at 2,063 shares worth $305K. The position accounts for 0.02% of the portfolio, ranked #405.

GLG LLC first reported a position in UTHR in Q1 2014 and has held it in 16 quarters since. The position peaked at $20.7M in Q4 2014. 400 funds tracked by Wall St. Rank hold UTHR as of Q4 2017.

  • GLG LLC held 2,063 shares of United Therapeutics worth $305K as of Q4 2017.
  • GLG LLC left its United Therapeutics share count unchanged in Q4 2017.
  • United Therapeutics made up 0.02% of GLG LLC's portfolio in Q4 2017, its #405 holding.
  • GLG LLC first reported a position in United Therapeutics in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's United Therapeutics position peaked at $20.7M in Q4 2014.
  • 400 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.